List of works - Daniel Stieber

A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.

scientific article

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

scientific article

Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

scientific article published on May 2014

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas

scientific article

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

scientific article published on 5 May 2017

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

scientific article published on 25 April 2019

Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1.

scientific article published on 6 August 2013

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis

scientific article published on 22 February 2013

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.

scientific article published on 24 October 2013

MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS.

scientific article published in July 2014

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

scientific article published on 25 March 2016

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

scientific article published on 03 October 2020

Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment

scientific article published on 16 April 2019

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

scientific article published on 30 May 2013

Tumor versus stromal cells in culture--survival of the fittest?

scientific article

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells

scientific article

List of works by Daniel Stieber

A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1.

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.

MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS.

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

Tumor versus stromal cells in culture--survival of the fittest?

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells